Clinical Trial Update: Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of combining XELOX with sintilimab and lenvatinib in patients with advanced AFP-positive gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lenvatinib (lenvatinib)
• OXALIPLATIN (Oxaliplatin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING